Edge Pharma, LLC recalls Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose Vials for Topical Use
Recalled February 2, 2022 · FDA recall D-0430-2022 · Edge Pharma
Hazard
CGMP Deviations · FDA Class II
Units
2204 vials
Sold at
nationwide
Description
CGMP Deviations
Product
Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose Vials for Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-0970-03
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →